Willow Short Term Debt from 2010 to 2025

WLLW Stock  CAD 0.01  0.01  50.00%   
Willow Biosciences Short Term Debt yearly trend continues to be very stable with very little volatility. Short Term Debt is likely to grow to about 882.7 K this year. During the period from 2010 to 2025, Willow Biosciences Short Term Debt quarterly data regression pattern had sample variance of 122.9 B and median of  587,000. View All Fundamentals
 
Short Term Debt  
First Reported
2004-12-31
Previous Quarter
671 K
Current Value
685 K
Quarterly Volatility
258.2 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Willow Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Willow Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 171.5 K, Selling And Marketing Expenses of 20.8 K or Other Operating Expenses of 17.7 M, as well as many indicators such as Price To Sales Ratio of 11.58, Dividend Yield of 0.0 or PTB Ratio of 4.37. Willow financial statements analysis is a perfect complement when working with Willow Biosciences Valuation or Volatility modules.
  
This module can also supplement various Willow Biosciences Technical models . Check out the analysis of Willow Biosciences Correlation against competitors.

Other Information on Investing in Willow Stock

Willow Biosciences financial ratios help investors to determine whether Willow Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.